Samrat Pharmachem Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 211.1 as of 30 Apr 15:30 . The P/E Ratio of Samrat Pharmachem Ltd is 0 as of March 2022 .The P/E Ratio of Zenith Drugs Ltd is 0 as of March 2022 . The Market Cap of Samrat Pharmachem Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Zenith Drugs Ltd is ₹ 0 crore as of March 2022 . The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The revenue of Zenith Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The ebitda of Zenith Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Zenith Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 yearsThe Dividend Payout of Zenith Drugs Ltd changed from 8.99 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

About Zenith Drugs Ltd

Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.
The Company is mainly engaged in the business of manufacturing and Trading of Medicines.

FAQs for the comparison of Samrat Pharmachem Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Zenith Drugs Ltd?

Market cap of Samrat Pharmachem Ltd is 65 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Zenith Drugs Ltd?

The stock performance of Samrat Pharmachem Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Zenith Drugs Ltd?

As of May 4, 2026, the Samrat Pharmachem Ltd stock price is INR ₹211.1. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Samrat Pharmachem Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.